Stay updated on Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry v3.5.4, replacing the previous v3.5.3, reflecting a minor update to the page's history.
    Difference
    0.1%
    Check dated 2026-05-14T23:26:46.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The Record History now shows Revision: v3.5.3, replacing the previous v3.5.2. This indicates the study record has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-04-30T15:33:44.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:28:09.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T20:10:46.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:13:25.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 entry was added to the record history, and a lengthy government funding status notice was removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:15.000Z thumbnail image

Stay in the know with updates to Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib vs Docetaxel in HER2 NSCLC Clinical Trial page.